Success Stories: Fast-Tracked EB2-NIW Approval for an Indian Data Science expert via the Premium Processing
Client’s Testimonial:
“Chen Immigration Law Firm truly stands out as the No. 1 in the field. From start to finish, their process was incredibly smooth and efficient. The team works ultra-fast, yet never compromises on attention to detail—they know exactly what USCIS wants to see in your petition, which gave me peace of mind throughout the entire process.
Beyond their technical expertise, the team is also highly responsive and supportive. They answered all my questions promptly and provided clear guidance every step of the way. I would highly recommend Chen Immigration Law Firm to anyone looking for top-notch service.”
On June 9th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Data Scientist in the Field of Data Science (Approval Notice).
General Field: Data Science
Position at the Time of Case Filing: Research Data Scientist
Country of Origin: India
State of Residence at the Time of Filing: Texas
Approval Notice Date: June 9th, 2025
Processing Time: 1 month and 16 days (Premium Processing Requested)
Case Summary:
NAILG (North America Immigration Law Group) recently received an inquiry from a research data scientist from India seeking assistance with his I-140 EB2-NIW (National Interest Waiver) petition. Specializing in data science, the client’s strong academic credentials and research achievements laid a solid foundation for a compelling case. We meticulously prepared a detailed petition highlighting his key accomplishments and supporting evidence. We are proud to announce that the client’s petition was approved swiftly in 1 month and 16 days through the direct premium processing.
Proposed endeavor of National Importance
Developing advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression is at the core of the client’s research. His proposed endeavor involves prioritizing and validating these cancer driver genes and integrating the findings into clinical workflows to improve diagnosis accuracy and prognosis, ultimately supporting personalized treatment strategies. This work addresses a critical need to reduce cancer’s impact on patients and the U.S. healthcare system, aligning with national priorities in public health.
Demonstration of notable academic and professional milestones
The client has built a strong scholarly profile through a combination of published research, peer recognition, and active participation in the scientific community. The following accomplishments were highlighted in the client’s petition:
● A remarkable publishing record of 9 peer-reviewed journal articles, 17 abstracts (including 1 as first author), and 1 preprint.
● His research has been cited 390 times, reflecting significant recognition and influence.
● Completed at least 31 peer reviews for prestigious journals and conferences, underscoring his expertise and active engagement in the field.
● Published in top journals such as The Lancet Oncology, The Lancet Child & Adolescent Health, JAMA Network Open, and Cancer.
● Authored 2 papers ranked among the top 1% most cited, 2 papers among the top 10% most cited, and 1 paper among the top 20% most cited articles in their respective years.
Timely approval granted with the Premium ProcessingNAILG’s strategic petition preparation secured the client’s I-140 EB2-NIW approval in just 1 month and 16 days through the direct premium processing. This swift approval reflects both the client’s strong credentials, the national importance of his research, and the strength of the petition prepared by us. We congratulate the client on this well-deserved achievement and look forward to his continued contributions to biomedical innovation and public health.